MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study

OBJECTIVE: To evaluate changes in structural damage and joint inflammation assessed by MRI following rituximab treatment in a Phase 3 study of patients with active rheumatoid arthritis (RA) despite methotrexate (MTX) who were naive to biological therapy. METHODS: Patients were randomised to receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterfy, Charles, Emery, Paul, Tak, Paul P, Østergaard, Mikkel, DiCarlo, Julie, Otsa, Kati, Navarro Sarabia, Federico, Pavelka, Karel, Bagnard, Marie-Agnes, Gylvin, Lykke Hinsch, Bernasconi, Corrado, Gabriele, Annarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717395/
https://www.ncbi.nlm.nih.gov/pubmed/25355728
http://dx.doi.org/10.1136/annrheumdis-2014-206015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717395/
https://www.ncbi.nlm.nih.gov/pubmed/25355728
http://dx.doi.org/10.1136/annrheumdis-2014-206015

Ejemplares similares